BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
53.56B
Enterprise Value 3
55.55B
Trailing P/E
10.62
Forward P/E 1
9.02
PEG Ratio (5 yr expected) 1
1.72
Price/Sales (ttm)
3.76
Price/Book (mrq)
3.86
Enterprise Value/Revenue 3
3.90
Enterprise Value/EBITDA 6
7.15

Trading Information

Stock Price History

Beta (5Y Monthly) 1.06
52-Week Change 3-6.15%
S&P500 52-Week Change 324.46%
52 Week High 3344.00
52 Week Low 3215.78
50-Day Moving Average 3292.92
200-Day Moving Average 3247.12

Share Statistics

Avg Vol (3 month) 32.24M
Avg Vol (10 day) 32.37M
Shares Outstanding 5180.44M
Float 180M
% Held by Insiders 10.47%
% Held by Institutions 193.42%
Shares Short (Nov 29, 2019) 44.24M
Short Ratio (Nov 29, 2019) 42.39
Short % of Float (Nov 29, 2019) 42.20%
Short % of Shares Outstanding (Nov 29, 2019) 42.35%
Shares Short (prior month Oct 31, 2019) 44.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/3
Last Split Date 3Jan 18, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 37.91%
Operating Margin (ttm)51.03%

Management Effectiveness

Return on Assets (ttm)17.14%
Return on Equity (ttm)38.87%

Income Statement

Revenue (ttm)14.23B
Revenue Per Share (ttm)73.87
Quarterly Revenue Growth (yoy)4.70%
Gross Profit (ttm)11.64B
EBITDA 7.77B
Net Income Avi to Common (ttm)5.4B
Diluted EPS (ttm)27.96
Quarterly Earnings Growth (yoy)7.00%

Balance Sheet

Total Cash (mrq)4.44B
Total Cash Per Share (mrq)24.59
Total Debt (mrq)6.43B
Total Debt/Equity (mrq)45.99
Current Ratio (mrq)1.91
Book Value Per Share (mrq)76.94

Cash Flow Statement

Operating Cash Flow (ttm)7.01B
Levered Free Cash Flow (ttm)4.48B